Paul is a pioneer in the field of patent law. In 1988, he obtained the first patent on a transgenic animal, the Harvard Mouse, which opened the door to the patenting of animals both here and in Europe. Since then, he has worked in virtually every area of biotechnology, including the discovery of small molecule therapeutics for the treatment of major medical disorders, recombinant proteins, gene therapy, and stem cell technology.
In 1996, Paul co-founded Clark + Elbing with Karen Elbing. His practice focuses on advising biotechnology and pharmaceutical clients on a wide range of complex intellectual property (IP) matters, including patent prosecution, licensing, interference, and re-examination, as well as the preparation of patentability, non-infringement, and invalidity opinions. He also has extensive experience in handling the IP issues that arise during due diligence, attendant to private financings and IPOs.
Before founding Clark + Elbing, Paul practiced law at Fish & Richardson P.C. from 1979 – 1996. He is the author or co-author of numerous presented papers and articles on biotechnology patent law.
- Best Lawyers in America
- Super Lawyers
- Member, Sigma Xi Scientific Research Society